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The simian immunodeficiency virus (SIV) nef gene is an important determinant of viral load and acquired immunodeficiency
syndrome (AIDS) in macaques. A role(s) for the HIV-1 nef gene in infection and pathogenesis was investigated by
constructing recombinant viruses in which the nef gene of the pathogenic molecular clone SIVmac239 nef was replaced with
either HIV-1SF2nef or HIV-1SF33nef. These chimeras, designated SHIV-2nef and SHIV-33nef, expressed HIV-1 Nef protein and
replicated efficiently in cultures of rhesus macaque lymphoid cells. In two SHIV-2nef-infected juvenile rhesus macaques and
in one of two SHIV-33nef-infected juvenile macaques, virus loads remained at low levels in both peripheral blood and lymph
nodes in acute and chronic phases of infection (for .83 weeks). In striking contrast, the second SHIV-33nef-infected
macaque showed high virus loads during the chronic stage of infection (after 24 weeks). CD41 T-cell numbers declined
dramatically in this latter animal, which developed simian AIDS (SAIDS) at 47–53 weeks after inoculation; virus was recovered
at necropsy at 53 weeks and designated SHIV-33Anef. Sequence analysis of the HIV-1SF33 nef gene in SHIV-33Anef revealed
four consistent amino acid changes acquired during passage in vivo. Interestingly, one of these consensus mutations
generated a tyr-x-x-leu (Y-X-X-L) motif in the HIV-1SF33 Nef protein. This motif is characteristic of certain endocytic targeting
sequences and also resembles a src-homology region-2 (SH-2) motif found in many cellular signaling proteins. Four
additional macaques infected with SHIV-33Anef contained high virus loads, and three of these animals progressed to fatal
SAIDS. Several of the consensus amino acid changes in Nef, including Y-X-X-L motif, were retained in these recipient animals
exhibiting high virus load and disease. In summary, these findings indicate that the SHIV-33Anef chimera is pathogenic in
rhesus macaques and that this approach, i.e., construction of chimeric viruses, will be important for analyzing the function(s)
of HIV-1 nef genes in immunodeficiency in vivo, testing antiviral therapies aimed at inhibiting AIDS, and investigating
adaptation of this HIV-1 accessory gene to the macaque host. © 1999 Academic Press
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Highly manipulatable non-human primate models are
ritical for elucidating mechanisms of pathogenesis in
IDS and for development of antiviral therapies and
accines. In macaques, human immunodeficiency virus
ype-1 (HIV-1) produces a low-level transient infection
ith no signs of immunodeficiency disease (Agy et al.,
992). Simian immunodeficiency virus (SIV), a primate
entivirus genetically related to HIV, infects and causes a
atal AIDS-like disease in susceptible macaques (Gard-
er and Luciw, 1997). Thus SIV infection of macaques
as become a useful and important animal model to
nalyze virus/host interactions, including the function(s)
f viral genes and regulatory elements in viral transmis-
ion, cell-tropism, viral load and persistence, and patho-
enesis, as well as evaluation of antiviral drugs and
accines. Because HIV-1 and SIV have a similar genetic
rganization and display homology throughout their ge-
omes (Shugars et al., 1993), it is possible to construct
ecombinant (chimeric) viruses that are replication-com-
1 To whom reprint requests should be addressed. Fax: (530) 752-
p914. E-mail: paluciw@ucdavis.edu.
235etent in vitro in tissue culture cells by substituting a
ene(s) of an infectious SIV clone with its HIV-1 counter-
art (Shibata et al., 1991). Such chimeras between SIV
nd HIV-1 are designated SHIV (reviewed in Overbaugh
t al., 1996). SHIV clones containing the HIV-1 tat, rev,
pu, and env genes readily infect several macaque spe-
ies, and, after one or more passages through animals,
xhibit a pathogenic phenotype (Joag et al., 1996;
eimann et al., 1996; Luciw et al., 1999). Accordingly,
HIV clones have become important for analyzing viral
henotypes controlled by the HIV-1 env gene and for the
valuation of anti-HIV-1 vaccines in the macaque model
f lentivirus infection and AIDS.
Both HIV-1 and SIV nef have been extensively ana-
yzed in vitro in cell culture systems and in vivo in ma-
aques to define the function(s) of this viral gene. In vitro
unctions ascribed to the nef gene are down-regulation
f cell surface CD4 antigen, degradation of MHC-I pro-
eins, modulation of cell activation pathways, and en-
ancement of virion infectivity (reviewed in Saksela,
997; Cullen, 1998). Nef is not required for viral replica-
ion in T-cell lines, although this gene enhances replica-
ion in unstimulated primary lymphocyte and macro-
hage cultures (Miller et al., 1995; Alexander et al., 1997).
0042-6822/99 $30.00
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236 MANDELL ET AL.dult macaques infected with a genetically engineered
IV mutant, containing a deletion in the nef gene
SIVmac239Dnef), showed low virus load and no disease
Kestler et al., 1991). Additionally, point mutations in SIV-
ac239 nef that affect certain Nef functions reverted in
ivo in juvenile macaques, and these reversions were
inked to increases in viremia and development of fatal
mmunodeficiency (Sawai et al., 1996; Khan et al., 1998).
nterestingly, some human long-term nonprogressors
arbor HIV-1 with deletions in nef (Deacon et al., 1995;
irchhoff et al., 1995). Although these aforementioned
tudies supported the importance of nef in viral patho-
enesis, fatal disease was produced in newborn ma-
aques infected with high doses of SIV clones containing
deletion in the nef gene (Baba et al., 1995; Wyand et al.,
997). Nonetheless in adults, nef is viewed as a signifi-
ant facilitator of viral disease (Baba et al., 1999).
Comparison of nef of SIVmac239 and several HIV-1
solates reveals similarities and differences. The Nef
roteins of both viruses contain a myristylated N termi-
us and show homology, largely in the central domain
Shugars et al., 1993). Nef of SIVmac contains ;50 ad-
itional amino acids near the N terminus that are not
ound in HIV-1 Nef. Recent studies, aimed at defining
unctional domains of both SIVmac239 and HIV-1 Nef,
uggest that not all such domains are homologous
Greenberg et al., 1998; B. M. Peterlin, personal commu-
ication). The interchangeability of SIV and HIV-1 nef has
een investigated by constructing recombinant viruses.
wo in vitro studies demonstrated that HIV-1 nef, when
ubstituted for SIV nef in the SIVmac239 clone, enabled
he chimeric virus to replicate efficiently in cultures of
acaque primary lymphocytes and a macaque T-cell line
Alexander et al., 1997; Sinclair et al., 1997). Macaques
xperimentally inoculated with SHIV clones containing
IV-1 nef, tat, rev, and env genes revealed that these
nimals showed low virus loads with no clinical signs of
mmunodeficiency disease (Igarashi et al., 1994; Shibata
t al., 1997). Animals in these studies were followed for
nly 4–6 months; thus, the long-term potential for viral
ersistence and pathogenesis was not addressed. Be-
ause the chimeric viruses tested in animals in the
forementioned studies contained several HIV-1 genes,
t is not feasible to assess the contribution(s) of HIV-1 nef
lone to the virus/host relationship. Accordingly, we con-
tructed SHIV clones that replaced nef of SIVmac239
ith nef from each of two distinct HIV isolates, HIV-1SF2
rom an individual in the early stages of AIDS (Levy et al.,
984) and HIV-1SF33 from a patient in the terminal stage
f AIDS (Cheng-Mayer, 1991). These chimeras, desig-
ated SHIV-2nef and SHIV-33nef, were analyzed for Nef
unction in vitro and tested in vivo in juvenile rhesus
acaques. One animal infected with SHIV-33nef showed
igh virus load and developed simian AIDS (SAIDS).
irus recovered at necropsy from this animal containedour to seven consistent amino acid changes in Nef; this iecovered virus subsequently produced high viral loads
nd SAIDS in additional juvenile macaques. The results
f this study indicate that chimeric viruses are a means
o analyze changes in HIV-1 nef sequences that might be
mportant for adaptation to a heterologous host, and to
xplore HIV-1 nef function in vivo.
RESULTS
n vitro characterization of SHIV-2nef and SHIV-33nef
ecombinants
Infectious virus was rescued from the SHIV-2nef and
HIV-33nef clones by transfection of cultures of
EMx174 lymphoid cells (see Fig. 9). Extensive cytopa-
hology developed in cultures 3–4 days after transfection
ith each chimeric virus, as well as with SIVmac239nef1
nd SIVmac239Dnef. Cell-free stocks of all these viruses
ere prepared in CEMx174 cultures, and infectivity titers
ere measured by end-point dilution in microtiter wells
ontaining CEMx174 cells. To assess the ability of the
HIVnef recombinants to replicate in macaque PBMC,
ultures of stimulated lymphocytes were inoculated with
ell-free stocks of SHIV-2nef and SHIV-33nef; compari-
ons were made to PBMC cultures infected with
IVmac239nef1 and SIVmac239Dnef. Levels of viral rep-
ication were measured, with an ELISA for SIV p27 gag
ntigen, in culture supernatants for 17 days. The two
himeric viruses replicated in macaque PBMC to levels
imilar to SIVmac239nef1 and SIVmac239Dnef (Fig. 1).
hus, the hybrid structures of SHIV-2nef and SHIV-33nef
llowed for efficient replication in vitro in primary lym-
hoid cells.
The function of the nef gene in the SHIVnef chimeras
as analyzed in an in vitro kinase assay, which as-
essed the ability of Nef to associate with and activate a
ellular serine/threonine kinase, designated Nef-associ-
ted kinase (NAK) and p21-activated kinase (PAK) (Sawai
t al., 1996). CEMx174 cells were infected with SHIV-2nef
nd SHIV-33nef, cell lysates were prepared at 5–7 days
fter infection, and NAK and PAK activities were tested in
oimmunoprecipitates prepared with anti-HIV-1 Nef an-
ibody. Both SHIV-2nef- and SHIV-33nef-infected cells
howed similar levels of NAK and PAK activity (Fig. 2A).
n additional experiments, the levels of Nef protein, de-
ermined by immunoblot analysis of infected cell lysates,
as similar for both chimeric viruses (these authors,
ata not shown).
nalysis of SHIVnef clones in macaques
To explore the ability of the chimeric viruses to repli-
ate in vivo and to test their pathogenic potential, two
uvenile rhesus macaques were inoculated intravenously
ith stocks of SHIV-2nef, and two additional animals
ere later infected with SHIV-33nef. These experimentsncluded comparisons with macaques infected with
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237SIV/HIV nef CHIMERIC VIRUS AND PATHOGENESISIVmac239nef1, which causes SAIDS, and the viru-
ence-attenuated clone SIVmac239Dnef. All animals
ere monitored for (i) signs of clinical disease, i.e. fever,
ymphadenopathy, splenomegaly, weight loss, hemato-
ogic abnormalities, and CD41 T-cell decline; (ii) cell-
ssociated virus in PBMC and lymph nodes and cell-free
irus in plasma; (iii) viral RNA expression and cellular
argets in necropsy tissues by in situ hybridization; and
iv) anti-viral antibody responses to virion core protein
p27 gag) by ELISA.
SHIV-2nef. Two macaques (Mmu 26120 and Mmu
6167) infected with SHIV-2nef showed no clinical or
aboratory signs of immunodeficiency or AIDS-like dis-
ase. The CD4/CD8 ratios, CD41 and CD81 T-cell num-
ers remained within reference range from before inoc-
lation (Week 0) values through the 83 weeks post-
noculation (PI) (data not shown). Both cell-associated
nd plasma virus loads in the two SHIV-2nef-infected
nimals were very low throughout the course of infection
Fig. 3A). Lymph node biopsies from Mmu 26120 and
mu 26167 showed only a mild follicular hyperplasia at
and 8 weeks PI (data not shown), when viral replication
as low in PBMC and lymph node cells (Fig. 3A, Table 1).
t 83 weeks PI, these SHIV-2nef-infected animals were
uthanized; post-mortem examinations for both animals
ere unremarkable.
SHIV-33nef. Two juvenile macaques (Mmu 27621 and
mu 27747) were inoculated with the second chimera,
HIV-33nef. Mmu 26721 remained healthy for .105
eeks PI, with no discernible clinical or pathologic ab-
ormalities. Virus levels, both cell-associated and in
lasma, in this animal were low in the acute and chronic
tages of infection (Fig. 3A, Table 1). CD41 and CD81
-cell counts remained within the reference range
FIG. 1. Replication of SHIVnef chimeras in vitro in macaque PB
IVmac239Dnef in in vitro cultures of rhesus PBMC. Each culture, cont
ach virus per cell. The level of viral replication was determined by mhroughout the course of infection; and at week 8 and 32 bI, peripheral lymph nodes from Mmu 27621 exhibited
nly mild follicular hyperplasia (data not shown).
In contrast, the second SHIV-33nef-infected animal,
mu 27747, developed diarrhea, marked CD41 T-cell
ecline, neutrophilia, and peritonitis between 47 and 53
eeks PI and was euthanized at 53 weeks PI (see
elow). At 2 weeks PI, this macaque exhibited relatively
igh virus load in peripheral blood, lymph nodes, and
lasma (Fig. 3A, Table 1). Subsequent to the 2-week time
oint, virus load declined and then exhibited a sustained
ncrease at 24 weeks PI and onward. This pattern of
iremia, high in the acute stage, with a decline followed
y an increase to high levels, was similar to the pattern
bserved in Mmu 27098, a positive control animal in-
ected with the pathogenic clone SIVmac239nef1 (Fig.
A, Table 1). Mmu 27747 showed mild follicular hyper-
lasia in peripheral lymph nodes at 8 weeks PI (data not
hown). However, striking changes were observed in
ymph node architecture at 32 weeks PI; marked lympho-
ollicular hyperplasia was characterized by expanded
ollicles with thin mantle zones, lymphoblastic lymphoid
ells in expanded germinal centers, and multiple follicles
resent deep in the medulla (data not shown). These
yperplastic lesions in lymph nodes of Mmu 27747 cor-
elated with high virus load (Fig. 3A, Table 1).
At the time of euthanasia at 53 weeks PI, Mmu 27747
isplayed a moderate lymphopenia (870 cells/ml), neu-
rophilia (12,470 neutrophils/ml), and severe decrease
n CD41 T cells (56 CD41 T cells/ml), in association
ith other signs of SAIDS, including diarrhea. Mmu
7747 also had a persistent neutropenia at weeks
2–42 weeks PI. All other hematologic parameters
ere within reference ranges. Pathologic findings at
ecropsy included septicemia, bacterial peritonitis,
HIV-2nef and SHIV-33nef were compared to SIVmac239nef1 and
106 PBMC in 1 ml medium, was inoculated at a m.o.i. of 0.2 TCID50 of
g SIV p27gag antigen levels in culture supernatants.MC. S
ainingacterial tonsillitis, lymphocytic gastroenteritis,
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238 MANDELL ET AL.arked lymphoid hyperplasia in the majority of lymph
odes, lymphoid depletion in selected gastrointestinal
ymph nodes, and chronic cholangiohepatitis. Tissues
aken at necropsy from Mmu 27747 were also exam-
ned for viral RNA expression by in situ hybridization.
here was evidence of viral replication in multiple
rgans. Large numbers of SIV RNA-positive cells were
etected in peripheral, abdominal, and thoracic lymph
odes, lung, and spleen, and within an intrabdominal
bscess. Combined in situ hybridization and immuno-
istochemistry revealed that the majority of infected
ells were macrophages with fewer numbers of CD31
FIG. 2. Assay for Nef-associated kinase (NAK) and p21-activated kinas
ith various viruses, and levels of NAK and PAK were determined in N
he phosphorylated cellular proteins p62 (indicator of NAK activity) a
EMx174 cells. Lanes 3 and 4, HUT78 cells infected with HIV-1SF2. Lan
ells infected with SHIV-33nef. (B) Lanes 1 and 2, uninfected CEMx174
, CEMx174 cells infected with SHIV-33Anef.cells positive for viral RNA (Fig. 4). Disease in sus- Neptible primates infected with pathogenic lentivi-
uses is characterized by CD4 T-cell depletion in lym-
hoid tissues and persistent infection of macrophages
Embretson et al., 1993; Veazey et al., 1998). Virus
ecovered from PBMC obtained at necropsy from Mmu
7747 was designated SHIV-33Anef.
Mmu 26939, infected with SIVmac239Dnef, showed an
ncrease of virus load at 72 and 105 weeks PI; this animal
as euthanized at 105 weeks PI, and found to display
idespread lymphoid hyperplasia. Sequence changes in
irus from a necropsy sample of Mmu 26939 revealed
everal changes that produced a truncated form of SIV
) activation in SHIVnef-infected cells. Lymphoid cell lines were infected
PAK immunoprecipitates by in vitro kinase assays (Sawai et al., 1996).
(indicator of PAK activity) are labeled. (A) Lanes 1 and 2, uninfected
d 6, CEMx174 cells infected with SHIV-2nef. Lanes 7 and 8, CEMx174
Lanes 3 and 4, CEMx174 cells infected with SHIV-33nef. Lanes 5 ande (PAK
ef and
nd p72
es 5 an
cells.ef (Sawai et al., 1999).
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239SIV/HIV nef CHIMERIC VIRUS AND PATHOGENESISathogenesis in macaques infected with SHIV-33Anef
To test the pathogenic potential of SHIV-33Anef, four
uvenile rhesus macaques (Mmu 28815, Mmu 28883,
mu 28706, and Mmu 28872) were inoculated with
FIG. 3. Plasma virus load in SHIV-nef-infected macaques. SIV RNA
acaques infected with pathogenic wild-type virus SIVmac239nef1 and
IV RNA levels using bDNA signal amplification assay; the lower limit
HIV-2nef and SHIV-33nef. (B) Macaques infected with SHIV-33Anef (iHIV-33Anef, which was the uncloned virus recovered at mecropsy from Mmu 27747, the animal that died of SAIDS
t 53 weeks PI. In these four recipients of SHIV-33Anef,
evels of viral RNA in plasma (by bDNA assay) and levels
f cell-associated virus in PBMC and lymph nodes were
ma of macaques infected with SHIVnef chimeras were compared to
leted virus, SIVmac239Dnef. Plasma virus was assessed by measuring
itivity is 10,000 RNA copies/ml. (A) Macaques infected with the clones
s recovered from necropsy of Mmu 27747, the animal with SAIDS).in plas
nef-de
of sensarkedly higher than in animals infected with
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240 MANDELL ET AL.IVmac239Dnef (Fig. 3B and Table 1). In addition, virus
oad in these four SHIV-33Anef-infected macaques were
f equal magnitude or greater than those in Mmu 27747,
hich received the original SHIV-33nef clone and devel-
ped SAIDS (Fig. 3A and Table 1).
Importantly, the clinical condition of the SHIV-33Anef-
nfected animals was monitored. At 12 and 60 weeks PI,
T
Viral Load in Peripheral Blood Mononuclear Cells (PBMC
2 4 8
HIV2nef
Macaque 26120
PMBC 100 320 2
LNMC 462 ND 100
Macaque 26167
PBMC 320 32 3
LNMC 464 ND 32
HIV33nef
Macaque 27621
PBMC 316 47 275
LNMC 316 ND 32
Macaque 27747
PBMC 10,000 170 2,138
LNMC 21,54 ND 5,000
HIV33Anef
Macaque 28815
PBMC 4,217 1,000 15 2,
LNMC 31,623 464 ND
Macaque 28883
PBMC 10,000 2,154 3,162
LNMC 215,443 464 ND 10,
Macaque 28706
PBMC 3,162 457 2,154 3,
LNMC 3,162 464 ND
Macaque 28872
PBMC 10,000 3,162 1,000 10,
LNMC 21,544 ,10b
IVmac239nef1
Macaque 26084
PBMC 47,000 32,000 2,200 15,
LNMC 4,700 ND 17,000 46,
Macaque 27098
PBMC 22,000 470 100,000 1,
LNMC 4,700 ND 4,700 21,
IVmac239Dnef
Macaque 26873
PBMC 3,162 100 100
LNMC 215 ND 5
Macaque 26939
PBMC 146,780 3,162 68
LNMC 14,678 ND 464
Note. Viral load expressed as TCID50 per 10
6 PBMC or 106 LN cells. N
f detection for SHIVnefSF2 and SIVmac239Dnef.
a 107 PBMC positive for virus.
b Inadequate sample.
c Week 12 samples.
d Week 76 samples.espectively, Mmu 28872 and Mmu 28815 developed meveral clinical signs. Mmu 28815 showed weight loss,
nappetence, persistent watery diarrhea, nasal dis-
harge, severe neutropenia (369 neutrophils/ml), and de-
reasing CD4/CD8 T-cell ratios. Despite 10 weeks of
upportive therapy, clinical signs in Mmu 28815 in-
reased in severity culminating in depression, dehydra-
ion, anorexia, severe muscle wasting, cachexia, pale
h Node Cells (LNMC) in SIV & SHIV Infected Macaques
eks post-inoculation
24 32 42 52 83
,1a ,1 ,1a ,1 ,1
ND ,1 ND ,1 ,1
,1a 3 3 ,1 ,1
ND 10 ND ,1 ,1
5 3 42 3
ND 1,000 ND 100
2,754 19,953 2,291 3,162*
21,380 .1,000,000 ND 46,420*
46 32 316 464 1,000d
ND 46 ND 1,000 2,154d
3,162 585 2,540 422 1,708
ND 3,162 ND 1,708 ND
2,154
10,000 700 31,600 1,400*
ND 5,900 ND 3,750*
4,650 316 3,160 1,000 1,000*
ND 215,000 ND 4,650 320*
,1 ,1 ,1 ,1
2 ND ND 2
7 3 2 22
215 ND ND 1,708
one; *, virus load at necropsy. Virus loads in plasma were below limitsABLE 1
), Lymp
We
16
,1
316
,1
3
,1a
ND
215
ND
154
42
7
000
162c
000c,*
000
000
000
500
,1
ND
46
ND
D, not ducus membranes, decreased CD4/CD8 ratio of 0.5,
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241SIV/HIV nef CHIMERIC VIRUS AND PATHOGENESISD4 T-cell lymphopenia (CD4 T-cells 423/ml), marked
ypoproteinemia, and a left-shifted neutrophilic leukocy-
osis characteristic of an inflammatory response. This
nimal was euthanized at 79 weeks PI. Mmu 28872
howed a rapid deteriorating clinical course after infec-
ion with SHIV-33Anef. At 4 weeks PI, a transient anemia
nd hypoproteinemia was observed. At Weeks 12 and 14,
mu 28872 exhibited decreased appetite, mild nonre-
enerative anemia, and hypoproteinemia in the absence
f diarrhea. By 16 weeks PI, this animal was anorectic
nd cachectic due to marked weight loss; additional
bnormalities included CD4 T-cell lymphopenia, mildly
ecreased CD4/CD8 ratio from baseline, moderate non-
egenerative anemia (hemoglobin 8 gm/dl), severe hy-
oproteinemia, hypoalbuminemia, and regional periph-
ral lymphadenopathy. Euthanasia was performed at 16
eeks PI.
Post-mortem examination of the two clinically ill SHIV-
3Anef-infected macaques with disease was character-
zed by severe widespread lymphoid depletion and mul-
iple opportunistic infections. Both animals showed thy-
ic atrophy and severe gastrointestinal lesions, which
ere characterized by marked diffuse villous blunting
nd atrophy, and severe, diffuse gastrointestinal crypto-
poridiosis. Pulmonary Pneumocystis carinii infection
as also present. Mmu 28872 showed milder SIV-related
athologic lesions. In addition to lesions common to both
onkeys, Mmu 28872 had severe gastrointestinal infes-
ation with Trichomonas sp, which accounted for a mal-
bsorption syndrome, weight loss, and hypoproteinemia.
one marrow hypoplasia, was observed and explained
he nonregenerative anemia noted at Weeks 4, 15, and 16
I. Histiocytic-lymphocytic SIV-related encephalitis with
FIG. 4. Localization and expression of SHIVnef nucleic acid in lymp
nfected macaque that developed SAIDS. (A) SHIVnef-infected cells in l
irally infected cells. (Hematoxylin counterstain, 3250 magnification)
ombined in situ hybridization for viral nucleic acid (black grains) and
hows virus positive macrophages in lymph node of Mmu 27747 (AEC c
998).ynctia formation was present in the brain of Mmu w8872. Histopathologic lesions of Mmu 28815 were se-
ere and were dominated by widespread gastrointestinal
nfection with Cryptosporidia sp. These organisms ex-
ended into the pancreas and liver, causing pancreatitis,
iver abscessation, and peritonitis; and were also found
n the lung associated with bronchopneumonia. Dissem-
nated widespread lymphocytic-histiocytic infiltrates
ere present in the skin, salivary glands, gastrointestinal
ract, liver, and other soft tissues; this infiltrative lesion is
ypical of SIV pathogenesis. Acid fast positive Mycobac-
erium sp. organisms were also found in macrophages of
he lung, cecum, and colon.
equence changes in HIV-1 nef during SHIVnef
nfection in macaques
Because Mmu 27747 showed increased viral load at
4 weeks PI with SHIV-33nef and progressed to SAIDS,
e hypothesized that mutations important for pathogen-
sis developed in vivo in the HIV-1SF33 nef gene. To
xamine evolution of nef in vivo, nef sequences were
nalyzed at the early stage of infection (8 weeks PI) and
t two time points during the chronic stage (32 and 53
eeks PI). Importantly, sequence comparisons were
ade in nef between Mmu 27747, the animal exhibiting
AIDS, and Mmu 27621, the animal with low virus load
nd no disease. In addition, the HIV-1SF2 nef gene was
xamined in the asymptomatic SHIV-2nef-infected ma-
aques to determine whether alterations, such as dele-
ions, in this nef allele could explain the lack of patho-
enicity.
The pattern of amino acid sequence changes in the
nimal, Mmu 27747, with high virus load after infection
taken at necropsy (53 weeks PI) from Mmu 27747, the SHIV-33Anef-
ode of Mmu 27747 by in situ hybridization. Note black grains indicate
olocalization of SHIVnef nucleic acid in lymph node macrophages.
nohistochemistry for macrophage marker HAM-56 (red–orange stain)
gen with hematoxylin counterstain, 3400 magnification) (Veazey et al.,h node
ymph n
. (A) C
immu
hromoith SHIV-33nef, was complex. At 8 weeks PI, only 2 of 10
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242 MANDELL ET AL.lones exhibited no changes from prototype input nef.
he remaining 8 clones had one to three amino acid
hanges throughout nef; two clones acquired a prema-
ure stop codon at either position 84 or 140 (Fig. 5). By 32
eeks PI, when virus load approached high levels, 8 nef
lones each contained from three to nine changes (Fig.
). Consistent changes were as follows: val to ile at
osition 15 (7 clones), his to tyr at position 39 (6 clones),
la to thr at position 48 (4 clones), ala to asp at position
2 (5 clones), leu to val at position 75 (7 clones), and ile
o val at position 113 (8 clones). At 53 weeks PI, 14 nef
lones were analyzed, and identical changes to those
etected at 32 weeks were noted at positions 15, 39, 75,
nd 113 (Fig. 5). Positions 48, 49, and 52 were altered in
ost of the nef clones at 53 weeks PI; however, these
lterations involved substitution of two or more different
mino acids at each of these three positions. An impor-
ant issue is whether these sequence changes altered
ef function(s). In in vitro kinase assays, Nef of SHIV-33A
ssociated with NAK and PAK to similar levels as did Nef
f SHIV-33 (Fig. 2B). Thus passage of the chimeric virus
hrough Mmu 27747 did not affect levels of Nef protein or
he ability of Nef to associate with NAK and PAK in the
inase assays.
In contrast, the nef gene in the SHIV-33nef-infected
nimal, Mmu 27621, showing low virus load and no clin-
cal signs throughout the course of infection, contained
ery few changes in amino acid sequence at 32 weeks
I. Four clones, obtained by PCR amplification, each
isplayed only one amino acid change compared to the
rototype HIV-1SF33 nef sequence (Fig. 6). In the 53-week
amples from this animal, each of eight nef clones dis-
layed one to six amino acid differences from the proto-
ype. None of the Nef sequence changes in virus from
mu 27621 matched any of the changes in virus from
mu 27747 (Figs. 5 and 6).
To provide an additional comparison for evaluating the
equence changes in Nef of SHIV-33nef in vivo, virus
as recovered from Mmu 26120 and Mmu 26167 at 32
eeks PI with SHIV-2nef, and the nef genes were cloned
nd sequenced. Mmu 26167 nef clone 2.32-41 contained
amino acid changes: trp to cys at position 13, glu to gly
t position 112, glue to lys at position 158, glue to lys at
osition 159. Mmu 26120 two nef clones, 2.32-4 and
.32-29, each contained a change of trp to tyr at position
06. Importantly, these changes in Nef of virus recovered
rom the SHIV-2nef-infected animals did not match any
hanges in the SHIV-33nef- or SHIV-33Anef-infected an-
mals (Figs. 5 and 6).
To determine whether there was continued selection
n vivo for sequence changes in nef of SHIV-33Anef, nef
equences were analyzed in the three animals with
AIDS, Mmu 28815, Mmu 28872, and Mmu 28883. Figure
shows that all clones from these three animals re-
ained the alterations, his to tyr at position 39, and the ile
o val at position 113; these changes were present in all tlones of SHIV-33Anef recovered from necropsy of Mmu
7747. Additional consistent changes in the nef genes of
hese serial passage recipients were val to ile at position
5, and ala to either pro or asp at position 52 (Fig. 7). The
hange of leu to val at position 75 was retained in nef of
mu 28815 but not in nef of Mmu 28883 at 32 weeks
fter infection. These SHIV-33Anef-infected animals also
arbored a predominance of nef clones with alteration of
ys to arg at position 70.
DISCUSSION
This study examined SHIVnef chimeras in juvenile
hesus macaques with the aim of developing an animal
odel to analyze HIV-1 Nef function in vivo. A summary
f the animal inoculations and clinical outcomes is dia-
rammed in Fig. 8. One of two macaques inoculated with
HIV-33nef showed high virus load at 24 weeks PI and
rogressed to fatal SAIDS at 53 weeks PI. Our in vivo
ouble-labelling studies showed that macrophages were
he predominant cell expressing viral RNA in lymphoid
issues of SHIV-33nef-infected Mmu 27747 (Fig. 4). Only
ow numbers of virally infected T cells were detected.
his finding is supported by the recent cell culture stud-
es, which demonstrated that Nef induces macrophages
o produce CC-chemokines that mediate lymphocyte
hemotaxis and activation, thus enhancing the efficiency
f viral infection of T cells and presumably setting the
tage for T cell depletion (Swingler et al., 1999).
Both macaques infected with SHIV-2nef exhibited low
irus load and remained healthy for .83 weeks PI. Thus
he nef allele of HIV-1SF2 may be less efficient than the
IV-1SF33 nef allele at enabling the chimeric virus to
stablish a high viral replication rate to generate a patho-
enic variant. Interestingly, HIV-1SF2 was isolated from a
atient in the asymptomatic stage of infection, whereas
IV-1SF33 was recovered from a patient in the terminal
tage of AIDS. Both SHIV-2nef and SHIV-33nef replicated
o levels similar to SIVmac239nef1 in cultures of acti-
ated rhesus macaque PBMC, and both chimeras pro-
uced Nef proteins that associated with NAK and PAK to
imilar levels. In a large proportion of adult macaques
nfected with a clone of SIVmac239 bearing a large
eletion in nef, additional deletions accumulated in the
emaining nef sequences over time in vivo (Kirchhoff et
l., 1994). The nef region of SHIV-2nef in viruses recov-
red at 32 and 53 weeks PI of both Mmu 26120 and Mmu
6167 was analyzed by PCR amplification and DNA se-
uencing; these studies revealed that the nef gene was
ntact in virus in both of these animals. Accordingly, this
inding suggests that HIV-1SF2 nef expressed some level
f Nef function in vivo because the nef gene of the
himeric virus, SHIV-2nef, did not show evidence of ex-ensive deletion (Kirchhoff et al., 1995).
s
H
243SIV/HIV nef CHIMERIC VIRUS AND PATHOGENESISFIG. 5. Alignment of Nef sequences of virus recovered from Mmu 27747, which was infected with SHIV-33nef and developed SAIDS. The amino acid
equence for HIV-1SF33 Nef is shown above the solid line. Amino acids are designated by single letter code. Dashes indicate amino acid identity with
IV-1SF33. *, premature stop codons. Sequences for individual PCR clones are designated by the week PI and clone number.
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244 MANDELL ET AL.election for sequence changes in HIV-1 nef in vivo
In previous studies, sequence changes in HIV-1 env
enes were identified in rhesus macaques infected with
HIVenv chimeras (i.e., recombinant clones constructed
y replacing the SIVmac239 env gene with the counter-
art region of various HIV-1 clones). These sequence
hanges were associated with development of high viral
oad and progression to SAIDS (Stephens et al., 1997;
arlsson et al., 1998; Luciw et al., 1999). Accordingly, in
he present in vivo study, we examined nef gene se-
uences in SHIVnef-infected macaques. At 32 and 53
eeks PI, nef clones from Mmu 27747, the SHIV-33nef-
nfected animal exhibiting high virus load and SAIDS,
ontained three to nine amino acid changes from the
rototype sequence (Fig. 5). These changes fell into
hree categories: (i) four amino acids, at positions 15, 39,
5, and 113, were altered, each to the same new amino
cid in the majority of nef clones, (ii) amino acids at
ositions 48, 49, and 52 were altered to two or more
mino acids at each position in the majority of nef
lones, and (iii) two to four additional amino acid
hanges occurred throughout the nef sequence in each
lone (Fig. 5). SHIV-33Anef, the virus recovered at nec-
opsy at 53 weeks PI from Mmu 27747, was inoculated
FIG. 6. Alignment of Nef sequences of virus recovered from Mmu 2
or Fig. 5.nto four juvenile macaques (Fig. 8). All four recipient pnimals showed high virus loads; three have progressed
o fatal SAIDS. The nef clones in these recipients con-
ained the consistent changes at positions 15, 39, 75, and
13 of Nef that were observed in SHIV-33Anef recovered
rom Mmu 27747 (Figs. 5 and 7).
These consistent sequence changes in Nef of the
himeric viruses may be a consequence of selection for
IV-1 Nef proteins that interact efficiently with a cellular
rotein(s) mediating the function of this viral protein in
he simian host. The mutation of his to tyr at position 39
enerated a Y-X-X-L motif, which could represent a src-
omology region 2 (SH2) motif (Mayer and Gupta, 1998)
nd/or an endocytic signal motif (Kirchausen et al., 1997).
he YE and PBJ alleles of SIV nef contain an immunore-
eptor activation motif (ITAM) near the N terminus (Luo
nd Peterlin, 1997; Whetter et al., 1998); these alleles
onfer rapid disease potential on SIV (Du et al., 1995;
aucier et al., 1998). Because most ITAMs have at least
wo Y-X-X-L motifs, further analysis will be required to
etermine whether this motif in SHIV-33Anef functions as
n ITAM. Another notable change was leu to val at position
5 (Figs. 5 and 7); this leu in the prototype sequence is part
f the highly conserved SH3-ligand domain (i.e., pro-x-x-pro
otif) in Nef of primate lentiviruses (Saksela, 1997). It is
hich was infected with SHIV-33nef and remained healthy. See legend7621, wossible that such an alteration at position 75 influences
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245SIV/HIV nef CHIMERIC VIRUS AND PATHOGENESIShe affinity and/or specificity of HIV-1 Nef for a cellular
ignaling protein containing an SH3 domain. Positions 48,
9, and 52 were substituted with two or more different
mino acids at each of these three positions; it appears that
he ala residues at positions 49 and 52 were generally
FIG. 7. Alignment of Nef sequences of virus recovered from macaqu
AIDS. See legend for Fig. 5.ltered to amino acids with large side-groups (Figs. 5 and 1). The changes at these three positions are difficult to
nterpret because the structural model for Nef does not
nclude the first 60 amino acids at the N terminus; this
egion is believed to adopt a relatively unstructured confor-
ation under physiological conditions (Grzesiek et al.,
ch were infected with the recovered virus, SHIV-33Anef, and exhibitedes, whi996; Lee et al., 1996).
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246 MANDELL ET AL.It is also possible that sequence changes in Nef of the
himeric virus may be due to selection for more efficient
nteraction of Nef with another SIV protein. Recent find-
ngs with SHIVenv chimeras implicated a potential func-
ional relationship between the env glycoprotein and Nef.
nterestingly, either the YE or PBJ allele of SIV Nef was
ot sufficient to elicit pathogenicity in SHIVenv chimeras
ontaining the env genes of HIV-1HXB2 (Stephens et al.,
997), HIV-1SF162 (Luciw and Cheng-Mayer, unpublished
esults), and HIV-1DH12 (Shibata et al., 1997). These find-
ngs suggest a functional relationship between Nef and
he env glycoprotein. Because both the env glycoprotein
Hunter, 1997) and Nef (Aiken, 1997; Luo et al., 1998)
nfluence virion entry into cells, a plausible scenario is
FIG. 8. Summary of macaque inoculations with SHIVnef chimeras. Th
hesus macaques inoculated with the SHIV-2nef and SHIV-33nef clon
xhibiting high virus load and will be monitored for development of SAhat a change in one of these viral proteins may require r“compensating” change in the other to maintain full
irion infectivity. Accordingly, studies on SHIVnef chime-
as in vivo may provide novel insight on the functional
nterplay of viral genes. In addition, host immune re-
ponses to immunological epitopes in Nef may contrib-
te to sequence variation in vivo (McMichael and Philips,
997). HIV-1 Nef contains target epitopes for both helper
nd cytotoxic T-lymphocytes (CTL) (Korber et al., 1995).
mino acid sequences recognized by human CTL are
ocated throughout Nef, although the majority of CTL
pitopes are located in the central region of this viral
rotein. It is not practical to compare Nef epitopes in a
irect fashion between HIV-1-infected humans and
HIVnef-infected macaques without first establishing
e summarizes the experimental plan and clinical outcomes of juvenile
d uncloned SHIV-33Anef. Mmu 28706, infected with SHIV-33Anef, isis figur
es, anecognition patterns for HIV-1 Nef epitopes by macaque
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247SIV/HIV nef CHIMERIC VIRUS AND PATHOGENESISTL. Thus the SHIVnef system offers opportunities to
nvestigate the role of immune selection on HIV-1 Nef
nd thereby to better understand immunological factors
n viral adaptation and persistence.
tility of SHIVnef for in vivo analysis of Nef function
Whether amino acid changes in HIV-1 nef acquired
uring in vivo passage of SHIV-33nef are both necessary
nd sufficient for pathogenesis remains to be deter-
ined. Nucleotide sequence changes were not detected
n the polypurine tract (the primer for initiation of viral
lus-strand DNA during reverse transcription) or 59 end
f the U3 region (containing sequences recognized by
he viral integrase) of SHIV-33Anef (these authors, data
ot shown). It is possible that a change(s) in SIVmac
equences of the chimeric virus, in addition to changes
n HIV-1SF33 nef, may also be important for adaptation of
HIV-33Anef to the macaque host. Novel chimeric
lones, containing HIV-1 nef alleles from SHIV-33Anef,
an be constructed and analyzed in macaques to deter-
ine the significance of the changes, observed in HIV-
SF33 nef, for high virus load and pathogenesis. Addition-
lly, a measurable phenotype(s) based on an in vitro
ssay for Nef function (i.e., in tissue culture cells) will be
mportant for elucidating molecular mechanisms of
HIVnef immunodeficiency.
During the course of the studies reported in our paper,
nother group reported the in vivo analysis of SHIVnef
himeras built from the nef genes of the cell-line adapted
IV-1NL4-3 strain (Alexander et al., 1999). Persisting high
irus load and SAIDS were observed in about half of a
arge group of rhesus macaques infected with SHIVnef
himeras containing the HIV-1NL4-3 nef gene. This con-
rasts with our finding that SHIV-33Anef persisted at high
evels in four of four macaques; during the observation
eriod of ;2 years, three of these four animals devel-
ped fatal SAIDS. It is possible that the nature of the
IV-1 nef allele (NL4-3 vs SF33) influences virus load and
isease progression.
Evolution of HIV-1 in humans and SIV in susceptible
acaques involves changes in viral sequences (Wolin-
ky et al., 1996 and references therein); and these
hanges, largely affecting env gene functions, appear to
orrelate with progression to AIDS (Connor and Ho,
994; Rudensey et al., 1998). Several studies reported
hanges in nef sequence in HIV-1-infected individuals
nd chimpanzees in relation to disease progression
Huang et al., 1995; Mwaengo and Novembre, 1998; Salvi
t al., 1998) and/or organ tropism (McPhee et al., 1998);
owever, no firm conclusions have been made on the
mportance of such changes in nef to the development of
IDS. Accordingly, the results in this study, on the non-
athogenic and pathogenic pair SHIV-33nef and SHIV-
3Anef, respectively, set the stage for analyzing functions
f HIV-1 Nef and its domains in viral persistence and mathogenesis in non-human primate models for AIDS.
dditionally, SHIVnef chimeras can now be used to eval-
ate drugs and therapies targeted to HIV-1 Nef in the
on-human primate model for AIDS.
MATERIALS AND METHODS
ell and virus culture
Peripheral blood mononuclear cells (PBMC) were ob-
ained from healthy rhesus macaques free of simian
ype-D retroviruses (SRV), SIV, and simian T-lymphotropic
irus (STLV). These cells, purified from whole blood by
icoll–Hypaque centrifugation, were stimulated with
taphylococcal enterotoxin A (SEA) and maintained in
PMI 1640 medium supplemented with 10% heat-inacti-
ated (56°C for 30 min) fetal calf serum (FCS) and 10%
nterleukin-2 (Collaborative Research, Bedford, MA) and
ntibiotics (100 units/ml penicillin and 100 mg/ml strep-
omycin). CEMx174 cells, a human hybrid T-B cell line
ermissive for primate lentiviruses (provided by Dr. J.
oxie, University of Pennsylvania, Philadelphia, PA),
ere maintained in RPMI 1640 medium supplemented
ith 10% FCS and antibiotics. Titered stocks of cell-free
iruses were propagated in a 50 ml culture of CEMx174
ells. Culture supernatant was collected at 5–6 days
fter infection (when ;25% of cells displayed cytopathic
ffects), passed through a 0.22 mm filter, and frozen in 1
l aliquots. The 50% tissue culture infectious dose
TCID50) of these viral stocks in CEMx174 cells was
etermined by procedures described previously (Mar-
has et al., 1993).
onstruction of chimeric SHIV-2nef and SHIV-33nef
The cloned genome of SIVmac239 was modified to
ccommodate substitution of the SIV nef gene with a
NA fragment containing HIV-1 nef. The nef genes of the
lymphotropic, cytopathic HIV-1SF2, and HIV-1SF33 iso-
ates were selected; the former virus was recovered from
n asymptomatic HIV-1-positive individual prior to the
nset of AIDS, and the latter was isolated from an indi-
idual with AIDS. These two nef genes differ by 24 of 206
mino acids, primarily in the amino terminus. Because
he start of the SIVmac239 nef gene overlaps coding
equences near the 39 end of the env gene, the SIV-
ac239 molecular clone (GenBank Accession No.
33262) was modified by mutating two ATG codons
positions 9334 and 9352) near the 59 end of nef (Fig. 9).
hese changes were necessary to preclude synthesis of
ybrid (SIV/HIV-1) Nef proteins. The 39 portion of the
IVmac239 genome, from the SphI site in vpr through the
9 long terminal repeat (LTR) was cloned into pGEM-7Z
o produce pVP-2. Oligomutagenesis was performed to
utate the T in the two ATG codons at the beginning of
IV nef to C; this was done with the Muta-Gene Phage-
id Kit from BioRad (Richmond, CA) (Ausubel et al.,
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248 MANDELL ET AL.993). These mutations were verified by DNA sequenc-
ng. Additionally, a double-stranded oligonucleotide
olylinker was installed in the modified pVP-2 clone,
etween the end of the env gene (position 9499) and the
tuI site (position 10,085) in the U3 portion of the LTR.
his polylinker contains SalI, Afl3, HinfI, NdeI, and StuI
ites and the resulting plasmid was designated pVP-2B.
NA fragments with the HIV-1SF2 (GenBank Accession
o. K02007) and HIV-1SF33 (GenBank Accession No.
38427) nef genes were obtained by PCR amplification
rom the parental HIV-1 clones. For HIV-1SF2, the follow-
ng oligonucleotide primers were used: for the 59 end of
ef 59AGTCGACGAATTAGACAGGGCTTGGAAAGG39
SalI site in bold); for the 39 end of nef 59GAGGCCTTG-
AGAAAGCTCGATGTCAGC39 (StuI site in bold). For HIV-
SF33, the following oligonucleotide primers were used:
or the 59 end of nef 59GGTCGACTTTGCTATAAGAT-
GGTGGCAAGTGG39 (SalI site in bold), for the 39 end of
ef 59GAGTACTAGAAAGACTGCTGACATCGAGGCCTAA-
TCGAGG39 (StuI and XhoI sites in bold, respectively).
ecause the 59 and 39 primers contained a SalI and StuI
ite, respectively, the PCR amplified nef DNA fragments
ere cloned into the polylinker of pVP-2B by SalI/StuI
igest to produce pVP-2nef2 and pVP-2nef33. DNA se-
uencing was performed on the clones to verify the
equence of the polylinker and HIV-1 nef genes. To
roduce the full-length SHIVnef recombinant viruses, the
inearized 59 half of SIVmac239, designated pVP-1, was
igated with T4 DNA ligase to linearized pVP-2nef2 or
VP2nef33 to yield SHIV-2nef or SHIV-33nef, respectively.
o generate the biologically active virus, each of the
ull-length SHIVnef recombinants were transfected by
lectroporation into CEMx174 cells using a Bio-Rad Gene
ulser and Extender (Bio-Rad, Richmond, CA) as previ-
FIG. 9. Construction of the SHIVnef chimeric viruses. The 39 end of t
TR, is shown in the top panel. In SIVmac239, the nef gene overlaps wi
334 and 9352) were mutated by oligomutagenesis to ACG to preclude
nv (position 9499) and extending through the 39 LTR (position 10,083)
he 39LTR is a hybrid of HIV-1 and SIV sequences. The bottom panel susly described (Banapour et al., 1991). on vitro kinase assay
In vitro kinase assays were performed, as described
reviously, on immunoprecipitates obtained from lysates
f virally infected CEMx174 cells using either rabbit anti-
IV Nef antibody or rabbit anti-rat PAK-1 antibody (Santa
ruz Technologies, Santa Cruz, CA) (Sawai et al., 1996).
noculation of rhesus macaques with SHIVnef
ecombinants
Eight healthy, colony-bred retrovirus-free juvenile rhe-
us macaques, Macaca mulatta, between the ages of 2.5
nd 2.9 years and weighing 3.6–4.6 kg were used. All of
he monkeys were negative for antibodies for SRV, SIV,
nd STLV-1. Animals were housed and cared for at the
alifornia Regional Primate Research Center (CRPRC) at
avis, CA in accordance with American Association for
ccreditation of Laboratory Animal Care Standards. Ma-
aques were anesthetized with ketamine hydrochloride
o obtain blood and lymph node samples. Before inocu-
ation, 20 ml of blood was collected by venipuncture for
lasma, complete blood counts (CBC), and CD4/CD8
-cell immunophenotyping by flow cytometry. Also, prior
o virus inoculation and at serial time points after inoc-
lation, peripheral lymph nodes were obtained by exci-
ional biopsy and portions of lymph nodes were fixed in
0% buffered formalin, flash frozen in liquid nitrogen, and
reserved in OCT. Animals were observed daily and
eighed once weekly by the CRPRC veterinary staff.
omplete physical examinations were performed before
nd after inoculation to clinical illness. When clinical
igns of SAIDS were severe, animals were euthanized
ith an overdose of sodium pentobarbital. Titered stocks
nef constructs, including the 39 end of SIVmac239 env through the 39
9 portion of the env gene. The two SIV nef ATG start codons (positions
ational initiation in SIV nef sequences. The region between the end of
placed with the nef gene of either HIV-1SF2 or HIV-1SF33. Accordingly,
the full proviral form of the SHIVnef clone.he SHIV
th the 3
transl
was ref cell-free SHIV-2nef and SHIV-33nef prepared in
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249SIV/HIV nef CHIMERIC VIRUS AND PATHOGENESISEMx174 cells were used to intravenously inoculate
ach macaque at 1000 TCID50 of virus.
easures of viral load and antiviral antibodies
For measuring plasma viremia, serial 10-fold plasma
ilutions were made in tissue culture medium and dis-
ensed into 24-well microtiter plates containing 2.5 3
05 CEMx174 cells (Marthas et al., 1993). For measuring
ell-associated viral loads, 106 PBMC or lymph node
ononuclear cells (LNMC), and serial 10-fold dilutions of
hese cells, from each infected macaque were cocul-
ured with 2.5 3 105 CEMx174 cells per well with 4 wells
er dilution. These cultures were observed for cytopa-
hology by light microscopy, and culture medium was
ssayed for SIV p27gag antigen by ELISA (Coulter, Hi-
leah, FL) to monitor virus production. Titers were cal-
ulated by the method of Reed and Meunch to determine
he number of infected PBMC per 106 total PBMC (Mar-
has et al., 1993). In addition, levels of viral RNA in
lasma samples of infected macaques were determined
y bDNA assay (Chiron Corp., Emeryville, CA) (Dailey et
l., 1995). To measure anti-SIV antibodies, serial twofold
ilutions of plasma were evaluated using an ELISA con-
aining purified whole HIV-2 that crossreacts with SIV
Genetic Systems, Seattle, WA).
ematologic evaluation and T-cell
mmunophenotyping
CBC were performed by a standard automated method
Biochem Immunosystems, Allentown, PA) on EDTA an-
icoagulated blood. CD41 and CD81 T-cell immunophe-
otyping was performed by flow cytometry using a two-
olor whole-blood lysis technique (Q-Prep, Coulter, Hi-
leah, FL) (Reimann et al., 1994). Fifty microliters of
hole blood was incubated in the dark at 25°C with
nti-CD4 (Leu3a; Becton Dickinson, Mountain View, CA)
nd anti-CD8 (Leu2a, Becton Dickinson, Mountain View,
A) specific monoclonal antibodies according to manu-
acturer’s instructions and were analyzed by flow cytom-
try using a FACScan (Becton Dickinson).
etection of virus in tissues
Combined in situ hybridization/immunohistochemistry
as performed as previously described (Mandell et al.,
995). A 4.5-kb SIVmac239 genomic DNA fragment con-
aining the gag and pol regions was radioactively labeled
ith [35S]CTP by random priming in a DNA polymerase
eaction to synthesize a SIV DNA probe with a specific
ctivity of $1 3 108 cpm/mg. To detect both SIV DNA and
NA, coverslipped slides were heated at 95°C for 7 min.,
ooled on ice for 3 min., then incubated overnight at
7°C in humidification chambers. In situ hybridization
xperiments were repeated at least three times to verify
onsistency of results. Control samples included 4%
araformaldehyde fixed SIV-infected and uninfected cul- lured CEMx174 cells, hybridization of lymph node and
astrointestinal tissue from SIV-infected and uninfected
onkeys, hybridization with probe containing only the
SP64 vector, and RNase treatment of tissue before
ybridization. Monocyte/macrophages and T lympho-
ytes were localized, respectively, using the HAM-56
onoclonal antibody specific for macrophages (DAKO
orporation, Carpentieria, CA) and a polyclonal antibody
pecific for CD31 T-cells (DAKO Corporation). These
ntibodies have been validated for use on uninfected
nd infected rhesus macaque tissues (Mandell et al.,
995).
ecovery and sequence analysis of HIV-1 nef from
nfected macaques
At various times after inoculation, LNMC and PBMC
ere collected from macaques infected with SHIV-2nef,
HIV-33nef, or SHIV-33Anef. DNA was extracted using a
ommercial kit according to manufacturer’s instructions
QIAmp Blood Kit, Qiagen, Chatsworth, CA). The region
ontaining HIV-1 nef was amplified by nested polymer-
se chain reaction (PCR) using standardized protocols.
etails of PCR amplification, conditions and DNA se-
uencing are available upon request from the authors.
mportantly, multiple PCR amplifications were performed
o obtain nef clones from the animals in this study.
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Note added in proof. The macaque infected with SHIV-33Anef,
mu 28883, was euthanized at 117 weeks postinoculation because
f SAIDS-related disease. This animal showed moderate to high
iral load throughout infection. Prior to euthanasia, Mmu 28883
eveloped marked weight loss, diarrhea and colitis, and an exten-
ive rash and dermatitis. At necropsy, widespread lymphoid hyper-
lasia was noted in all lymphoid organs (lymph nodes, thymus,
pleen, gastrointestinal and pulmonary lymphoid tissues) as well as
arly lymphoid depletion in the spleen. In addition to generalized
ymphoid hyperplasia, the diffuse, extensive dermatitis with second-
ry bacterial infection and the increased severity of the ulcerative
olitis lesions are related to infection with immunodeficiency lenti-
iruses in primates. Virus load at necropsy of Mmu 28883, measured
y bDNA assay, was in the high range at 2.2 3 106 viral RNA
quivalents per ml of plasma (Fig. 3B). The remaining SHIV-33Anef-
nfected animal, Mmu 28706, continues to maintain high virus load,
reater than 5 3 105 viral RNA equivalents per ml of plasma at 52
eeks after infection (Fig. 3B). During the preparation of this paper,
nother report on SHIVnef pathogenesis in macaques was pub-ished by Kirchhoff and colleagues (J. Virol. 73, 8371–8383, 1999).
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